Abionyx shares shoot up on deal to buy IRIS Pharma

Abionyx Pharma SA

18/11/2021 08:51

** Shares in Abionyx Pharma  ABNX.PA  jump 30% after the
French biopharmaceutical group said it had signed a deal to buy
the owner of ophthalmological firm IRIS Pharma  urn:newsml:reuters.com:*:nL1N2S822F
    ** The company said it would fully finance the deal, which
values IRIS Pharma Holding at EUR 5 million ($5.66 million)
    ** Abionyx will thus launch a capital increase in cash by
private placement at a fixed price of EUR 3.60 per share
    ** Midcap Partners says the deal is "an opportunity to
quickly penetrate the ophthalmology segment"
    ** The stock of Abionyx, which is up by nearly 100%
year-to-date, soared as much as 46% in early trading, reaching
its highest point in almost four years

($1 = 0.8835 euros)

 (Reporting by Juliette Portala)
 ((juliette.portala@tr.com))